Maurits Wondergem

1.7k total citations
63 papers, 1.1k citations indexed

About

Maurits Wondergem is a scholar working on Pulmonary and Respiratory Medicine, Radiology, Nuclear Medicine and Imaging and Surgery. According to data from OpenAlex, Maurits Wondergem has authored 63 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pulmonary and Respiratory Medicine, 29 papers in Radiology, Nuclear Medicine and Imaging and 15 papers in Surgery. Recurrent topics in Maurits Wondergem's work include Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (27 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Maurits Wondergem is often cited by papers focused on Prostate Cancer Treatment and Research (33 papers), Prostate Cancer Diagnosis and Treatment (27 papers) and Radiopharmaceutical Chemistry and Applications (17 papers). Maurits Wondergem collaborates with scholars based in Netherlands, United States and Germany. Maurits Wondergem's co-authors include Remco J.J. Knol, Friso M. van der Zant, Wouter A.M. Broos, Maurice A. A. J. van den Bosch, J. Frank W. Nijsen, Marnix G. E. H. Lam, Daniela E. Oprea‐Lager, André N. Vis, M. A. D. Vente and Bernard A. Zonnenberg and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Maurits Wondergem

60 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Maurits Wondergem Netherlands 16 729 576 264 202 175 63 1.1k
Richard Hoau Gong Lo Singapore 16 542 0.7× 164 0.3× 384 1.5× 290 1.4× 175 1.0× 34 995
Seza A. Güleç United States 20 375 0.5× 541 0.9× 446 1.7× 245 1.2× 403 2.3× 43 1.3k
Karen Kranda United States 14 711 1.0× 155 0.3× 61 0.2× 191 0.9× 160 0.9× 15 974
Paul C.M.S. Verhagen Netherlands 19 1.6k 2.2× 371 0.6× 35 0.1× 239 1.2× 196 1.1× 49 1.9k
Roberto Cianni Italy 19 270 0.4× 286 0.5× 335 1.3× 476 2.4× 216 1.2× 49 1.1k
Joseph Espat United States 10 419 0.6× 195 0.3× 587 2.2× 346 1.7× 367 2.1× 14 1.0k
Çiğdem Soydal Türkiye 16 293 0.4× 305 0.5× 154 0.6× 197 1.0× 240 1.4× 98 730
G Pizzi Italy 15 386 0.5× 302 0.5× 502 1.9× 342 1.7× 224 1.3× 50 1.0k
Christopher Parker United Kingdom 12 286 0.4× 214 0.4× 44 0.2× 54 0.3× 162 0.9× 30 665
Fabrice Gutman France 10 231 0.3× 391 0.7× 138 0.5× 102 0.5× 233 1.3× 20 716

Countries citing papers authored by Maurits Wondergem

Since Specialization
Citations

This map shows the geographic impact of Maurits Wondergem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Maurits Wondergem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Maurits Wondergem more than expected).

Fields of papers citing papers by Maurits Wondergem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Maurits Wondergem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Maurits Wondergem. The network helps show where Maurits Wondergem may publish in the future.

Co-authorship network of co-authors of Maurits Wondergem

This figure shows the co-authorship network connecting the top 25 collaborators of Maurits Wondergem. A scholar is included among the top collaborators of Maurits Wondergem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Maurits Wondergem. Maurits Wondergem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Smit, Laura A., Jan Paul de Boer, Arash Navran, et al.. (2025). [18F]FDG-PET/CT’s change in total lesion glycolysis can accurately identify early response upon neoadjuvant immunotherapy prior to curative-intent surgery in cutaneous squamous cell carcinoma; MATISSE trial. European Journal of Nuclear Medicine and Molecular Imaging. 53(4). 2217–2233.
2.
Leeuwen, Pim J. van, Maurits Wondergem, Thierry N. Boellaard, et al.. (2024). A Systematic Review on the Diagnostic Value of Fibroblast Activation Protein Inhibitor PET/CT in Genitourinary Cancers. Journal of Nuclear Medicine. 65(6). 888–896. 9 indexed citations
3.
Donswijk, Maarten L., et al.. (2024). The intra- and interobserver variability of PSMA-expression scores in patients with primary prostate cancer. EJNMMI Research. 14(1). 99–99. 2 indexed citations
4.
Donswijk, Maarten L., et al.. (2023). Incidence of PSMA PET thyroid incidentaloma depends on analysis method and tracer. European Radiology. 33(5). 3377–3385. 3 indexed citations
5.
Oprea‐Lager, Daniela E., André N. Vis, R. Jeroen A. van Moorselaar, et al.. (2023). Optimization and validation of 18F-DCFPyL PET radiomics-based machine learning models in intermediate- to high-risk primary prostate cancer. PLoS ONE. 18(11). e0293672–e0293672. 8 indexed citations
6.
Richters, Anke, Richard P. Meijer, Maurits Wondergem, et al.. (2023). Staging fluorodeoxyglucose positron emission tomography/computed tomography for muscle‐invasive bladder cancer: a nationwide population‐based study. British Journal of Urology. 132(4). 420–427. 3 indexed citations
7.
Hiel, Bernies van der, Else A. Aalbersberg, Maurits Wondergem, et al.. (2022). 18F-FDG PET/CT During Neoadjuvant Targeted Therapy in Prior Unresectable Stage III Melanoma Patients. Clinical Nuclear Medicine. 47(7). 583–589. 7 indexed citations
8.
Donswijk, Maarten L., Maurits Wondergem, Berlinda J. de Wit–van der Veen, et al.. (2022). Effects of furosemide and tracer selection on urinary activity and peri-bladder artefacts in PSMA PET/CT: a single-centre retrospective study. EJNMMI Research. 12(1). 42–42. 9 indexed citations
9.
Meijer, Dennie, Pim J. van Leeuwen, Yves J. L. Bodar, et al.. (2021). Management impact of 18F-DCFPyL PET/CT in hormone-sensitive prostate cancer patients with biochemical recurrence after definitive treatment: a multicenter retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. 48(9). 2960–2969. 10 indexed citations
10.
Meijer, Dennie, B.H.E. Jansen, Maurits Wondergem, et al.. (2020). Clinical verification of 18F-DCFPyL PET-detected lesions in patients with biochemically recurrent prostate cancer. PLoS ONE. 15(10). e0239414–e0239414. 9 indexed citations
11.
Jansen, B.H.E., Yves J. L. Bodar, Gerben J.C. Zwezerijnen, et al.. (2020). Prospective evaluation of pelvic lymph node staging with 18fluorine prostate-specific membrane antigen PET/CT prior to extended lymph node dissection in primary prostate cancer – the SALT trial. European Urology Open Science. 19. e1699–e1699. 1 indexed citations
12.
Jansen, B.H.E., Yves J. L. Bodar, Gerben J.C. Zwezerijnen, et al.. (2020). Pelvic lymph-node staging with 18F-DCFPyL PET/CT prior to extended pelvic lymph-node dissection in primary prostate cancer - the SALT trial -. European Journal of Nuclear Medicine and Molecular Imaging. 48(2). 509–520. 78 indexed citations
13.
14.
15.
Broos, Wouter A.M., Maurits Wondergem, Friso M. van der Zant, Nicolaas C. Schaper, & Remco J.J. Knol. (2020). Dynamic 18F-fluorocholine PET/CT for parathyroid imaging in patients with primary hyperparathyroidism. Nuclear Medicine Communications. 41(8). 776–782. 8 indexed citations
16.
Wondergem, Maurits, B.H.E. Jansen, Friso M. van der Zant, et al.. (2019). Early lesion detection with 18F-DCFPyL PET/CT in 248 patients with biochemically recurrent prostate cancer. European Journal of Nuclear Medicine and Molecular Imaging. 46(9). 1911–1918. 46 indexed citations
17.
18.
Wondergem, Maurits, et al.. (2018). Incidental Detection of a Melanoma by 18F-Fluorocholine PET/CT Performed for Evaluation of Primary Hyperparathyroidism. Clinical Nuclear Medicine. 43(4). 265–266. 6 indexed citations
19.
Lazarenko, Sergiy V., Friso M. van der Zant, Xiao-Bo Pan, et al.. (2017). Cardiac Displacement During 13N-Ammonia Myocardial Perfusion PET/CT: Comparison Between Adenosine- and Regadenoson-Induced Stress. Journal of Nuclear Medicine Technology. 46(2). 114–122. 9 indexed citations
20.
Wondergem, Maurits, Monique G. G. Hobbelink, Arjen J. Witkamp, Richard van Hillegersberg, & Bart de Keizer. (2012). Breast cancer sentinel node scintigraphy. Nuclear Medicine Communications. 33(11). 1138–1143. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Richard Hoau Gong Lo Breakdown of academic impact, for papers by Seza A. Güleç Breakdown of academic impact, for papers by Karen Kranda Breakdown of academic impact, for papers by Paul C.M.S. Verhagen Breakdown of academic impact, for papers by Roberto Cianni Breakdown of academic impact, for papers by Joseph Espat Breakdown of academic impact, for papers by Çiğdem Soydal Breakdown of academic impact, for papers by G Pizzi Breakdown of academic impact, for papers by Christopher Parker Breakdown of academic impact, for papers by Fabrice Gutman
Rankless by CCL
2026